Recombinant human alkaline phosphatase(AM-Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human alkaline phosphatase(AM-Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionImmunomodulatorsCytokines modulators
TargetsCytokines
Therapy Area/IndicationsAcute Kidney InjuryShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAM-Pharma BV
China Registration ClassN/A

Develop Information

Active CompaniesAM-Pharma BVRadboud University Nijmegen
Inactive CompaniesN/A
Active IndicationsAcute Kidney InjuryShock, Septic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A